公司资料
Phio Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- PHIO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.02 USD (+2.09%)
收盘价
最后更新: 2026年9月17日
13M USD
市值
股价为何变动
截至 2026年9月17日，PHIO 上涨 2.09%，收于 $1.02。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Phio Pharmaceuticals is a biotechnology company focused on immune-oncology and RNA interference-based approaches to cancer. Its story centers on using gene-silencing science to improve tumor treatment.
所在地与行业分类
Phio is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
商业模式特征
The company depends on preclinical and early clinical validation, capital discipline, and the ability to show that its platform can create a meaningful cancer signal. Investors usually watch translational progress and financing runway.
生物医药行业定位
Phio occupies a speculative RNAi-oncology niche within biotech. The stock is catalyst-sensitive because the company is still proving whether its platform can matter clinically.
未来催化剂
- Phio’s catalysts are its immune-oncology platform and any clinical or partnership update that shows the technology can still produce value. The company remains early and data-dependent.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。